Bioengineering & Translational Medicine: Year 2020 in review

Abstract

Huge thanks to all BioTM authors who trusted the journal with their precious manuscripts in the early, unproven days. Submission of high-quality manuscripts is the principal reason that led to an impressive launching impact factor. BioTM welcomes manuscripts in all aspects of bioengineering including drug delivery, drug discovery and development, tissue engineering, synthetic biology, biosensors, organoids and organ-mimetic systems, stem cell therapies, gene therapies, immunotherapies, patient-targeted therapies, medical devices, regenerative medicine, implant/patient interface, computational modeling, and bioinformatics. Areas including drug delivery, gene therapy, sirRNA delivery, regenerative medicine, nanomedicine, biomedical devices, and cell therapy have been particularly well represented in the manuscripts recently submitted to BioTM. This is expected because these fields represent some of the most active research areas at the interface of medicine and engineering, especially those that focus on developing/